Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 16, 2024; 12(17): 2983-2988
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2983
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2983
Efficacy and safety of percutaneous transhepatic biliary radiofrequency ablation in patients with malignant obstructive jaundice
Ying Xing, Zheng-Rong Liu, You-Guo Li, Hong-Yi Zhang, Department of General Surgery, Tiantan Hospital, Beijing 100170, China
Author contributions: Xing Y and Liu ZR wrote the manuscript; Xing Y and Zhang HY performed the research; Liu ZR and Li YG designed the research study; All authors have read and approve the final manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Beijing Tiantan Hospital, Approval No. KYSQ 2020-177-01.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Yi Zhang, MD, Surgeon, Department of General Surgery, Tiantan Hospital, No. 119 Fanyang Street, Beijing 100170, China. zhy13910433778@163.com
Received: December 24, 2023
Revised: April 18, 2024
Accepted: May 6, 2024
Published online: June 16, 2024
Processing time: 163 Days and 1.5 Hours
Revised: April 18, 2024
Accepted: May 6, 2024
Published online: June 16, 2024
Processing time: 163 Days and 1.5 Hours
Core Tip
Core Tip: Studied the efficacy and safety of endobiliary radiofrequency ablation using percutaneous transhepatic cholangiodrainage in 17 patients with malignant obstructive jaundice, all patients successfully completed the operation, total bilirubin and direct bilirubin decreased significantly after operation; perioperative biliary bleeding occurred in 2 patients, which was improved after transfusion of blood and other conservative treatments, pancreatitis appeared in 1 patient after the operation, and was improved by medication; during follow-up, the stent patency rate was 100% 71% and 29% at the 1st, 3rd, and 6th postoperative months respectively, with a median survival of 4 months.